DeutschNewstral
Article
jdsupra.com on 2022-08-02 18:43
EU General Court upholds European Commission’s decision on Illumina/GRAIL merger referral
Related news
- General Court Upholds European Commission’s Power to Review Illumina-Grailjdsupra.com
- General Court Upholds European Commission’s Power to Review Illumina-Grail Despite Untriggered Turnover Thresholdsjdsupra.com
- General Court Decision in Illumina / Grail Vindicates Commission’s Article 22 Referral Policyjdsupra.com
- Illumina/Grail: Court Opinion Could See an End to the EU Commission’s Expansive Merger Review Policyjdsupra.com
FTC orders San Diego's Illumina to unwind $7.1B Grail mergersandiegouniontribune.com- FTC's Drop Of Illumina-Grail Merger Case Raises Uncertaintyjdsupra.com
- New twist in the Illumina/GRAIL saga: Advocate General challenges European Commission’s power to review below-threshold mergersjdsupra.com
- Illumina/GRAIL: EU General Court gives green light to below-threshold merger referralsjdsupra.com
- Illumina/Grail—The Dawn of a New Era for Global Merger Control?jdsupra.com
- Carl Icahn turns up heat on Illumina, claims board got extra insurance ahead of Grail mergersandiegouniontribune.com
- FIllumina pushes ahead with closing $8bn Grail merger in defiance of EU probeft.com
Illumina Inc: Grail alumni say Illumina battle threatens cancer breakthroughFinancial Times- MFTC orders Illumina to divest Grail acquisitionmvtelegraph.com
Illumina to divest cancer test maker GrailNew York Post- Illumina vs European Commission: the EU General Court endorses the Commission’s new approach to Article 22 EUMR allowing the capture of mergers below the thresholdsjdsupra.com
- Affaire Illumina / Grail : La Commission européenne Dit « Pause ! »jdsupra.com
- Illumina says there is outside interest in buying Grailsandiegouniontribune.com
- Safety net or overreach? The European Commission’s new policy on Member State merger referralsjdsupra.com
Illumina bietet für Krebstest-Hersteller Grail acht Milliarden DollarReuters